ORIENT-12 Study demonstrates adding sintilimab to gemcitabine/platinum has clinical benefit

(International Association for the Study of Lung Cancer) Adding sintilimab to a regimen of gemcitabine and platinum demonstrates clinical benefit over gemcitabine and platinum alone as first-line therapy in patients with locally advanced or metastatic squamous cell non-small cell lung cancer, according to a study published in the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news